ID   GM23878
AC   CVCL_5T28
DR   Coriell; GM23878
DR   Wikidata; Q54853413
RX   PubMed=23665875;
RX   PubMed=26621101;
RX   PubMed=29474986;
RX   PubMed=31401124;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
RX   PubMed=23665875; DOI=10.1534/g3.113.006577; PMCID=PMC3704242;
RA   Tang Z.-Y., Berlin D.S., Toji L.H., Toruner G.A., Beiswanger C.M.,
RA   Kulkarni S., Martin C.L., Emanuel B.S., Christman M., Gerry N.P.;
RT   "A dynamic database of microarray-characterized cell lines with
RT   various cytogenetic and genomic backgrounds.";
RL   G3 (Bethesda) 3:1143-1149(2013).
//
RX   PubMed=26621101; DOI=10.1016/j.jmoldx.2015.08.005; PMCID=PMC4695224;
RA   Pratt V.M., Everts R.E., Aggarwal P., Beyer B.N., Broeckel U.,
RA   Epstein-Baak R., Hujsak P., Kornreich R., Liao J., Lorier R.,
RA   Scott S.A., Smith C.-Y.H., Toji L.H., Turner A., Kalman L.V.;
RT   "Characterization of 137 genomic DNA reference materials for 28
RT   pharmacogenetic genes: a GeT-RM collaborative project.";
RL   J. Mol. Diagn. 18:109-123(2016).
//
RX   PubMed=29474986; DOI=10.1016/j.jmoldx.2018.01.011;
RA   Pratt V.M., Del Tredici A.L., Hachad H., Ji Y., Kalman L.V.,
RA   Scott S.A., Weck K.E.;
RT   "Recommendations for clinical CYP2C19 genotyping allele selection: a
RT   report of the Association for Molecular Pathology.";
RL   J. Mol. Diagn. 20:269-276(2018).
//
RX   PubMed=31401124; DOI=10.1016/j.jmoldx.2019.06.007; PMCID=PMC6854474;
RA   Gaedigk A., Turner A., Everts R.E., Scott S.A., Aggarwal P.,
RA   Broeckel U., McMillin G.A., Melis R., Boone E.C., Pratt V.M.,
RA   Kalman L.V.;
RT   "Characterization of reference materials for genetic testing of CYP2D6
RT   alleles: a GeT-RM collaborative project.";
RL   J. Mol. Diagn. 21:1034-1052(2019).
//